Wms Partners, LLC Nymox Pharmaceutical Corp Transaction History

Wms Partners, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 08, 2022	SELL	$0.22 - $0.61 $5,280 - $14,640	-24,000 Reduced 57.14%	18,000 $7,000
Q1 2022 May 10, 2022	BUY	$1.21 - $2.0 $29,040 - $48,000	24,000 Added 133.33%	42,000 $53,000
Q1 2020 May 13, 2020	BUY	$1.69 - $3.88 $30,420 - $69,840	18,000 New	18,000 $42,000
Q4 2019 Feb 13, 2020	SELL	$1.73 - $2.42 $31,140 - $43,560	-18,000 Closed	0 $0
Q3 2019 Nov 07, 2019	BUY	$1.41 - $2.12 $25,380 - $38,160	18,000 New	18,000 $33,000

150K

Ticker NYMX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 91,265,000
Market Cap $42.9M
Description
Nymox Pharmaceutical Corporation, a biopharmaceutical company, engages in the research and development of drugs for the aging population in Canada, the United States, Europe, and internationally. Its lead drug candidate is Fexapotide Triflutate (NX-1207), which has completed Phase III clinical trials for the treatment of benign prostatic hyperpl...

Get notified when there are updates to the investment portfolio of Wms Partners, LLC, based on Form 13F filings with the SEC.

Stay updated on Wms Partners, LLC with notifications on news.